Opiant Pharmaceuticals (OPNT:NASDAQ) Investor Relations Material

Overview

Opiant Pharmaceuticals Inc. is a company on a mission to combat drug addiction and overdose. They have already made a breakthrough with their development of NARCAN® Nasal Spray, which is used to reverse opioid overdose. Now, they are working to build a strong portfolio of medicines to address various addictions. The company is poised for growth as addiction continues to be a major public health concern. With a focus on creating life-saving solutions, Opiant is quickly becoming a leader in the field of addiction medicine.

Frequently Asked Questions

What is Opiant Pharmaceuticals's ticker?

Opiant Pharmaceuticals's ticker is OPNT

What exchange is Opiant Pharmaceuticals traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Opiant Pharmaceuticals's headquarters?

They are based in Santa Monica, California

How many employees does Opiant Pharmaceuticals have?

There are 11-50 employees working at Opiant Pharmaceuticals

What is Opiant Pharmaceuticals's website?

It is opiant.com

What type of sector is Opiant Pharmaceuticals?

Opiant Pharmaceuticals is in the Healthcare sector

What type of industry is Opiant Pharmaceuticals?

Opiant Pharmaceuticals is in the Biotechnology industry

Who are Opiant Pharmaceuticals's peers and competitors?

The following five companies are Opiant Pharmaceuticals's industry peers:

- Regeneron Pharmaceuticals

- Trevena, Inc.

- C4X Discovery

- Plains All American Pipeline

- Anixa Biosciences